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Abstract
Introduction
Most studies on motivation and intention to quit smoking have been conducted among
adolescents and young adults but little is known regarding middle-aged subjects. We
aimed to assess the trends and determinants of smoking status in a population-based
cohort.
Method
Observational, prospective study with a first mean follow-up at 5.6 years and a second at
10.9 years. Data from 3999 participants (49.2% women, aged 35–75 years) living in Lau-
sanne (Switzerland).
Results
Baseline prevalence of never, former and current smokers was 41.3, 34.3 and 24.3%,
respectively. During the study period, more than 90% of never and former and almost 60%
of current smokers at baseline retained their status after 10.9 years. Among 973 current
smokers, 216 (22.2%) had quit for at least 5 years. Multivariable analysis showed increasing
age to be positively associated with quitting (p-value for trend <0.001). Among 1373 former
smokers, 149 (10.9%) had relapsed; increasing age (p-value for trend <0.001) was nega-
tively associated and family history of lung disease was positively associated with relapse
[OR and 95% CI: 1.53 (1.06–2.21)]. Among 1653 never smokers, 128 (7.7%) initiated smok-
ing; Male gender [1.46 (1.01–2.12)] and living in coupled relationship [0.66 (0.45–0.97)]
were associated with smoking initiation.
Conclusion
Most middle-aged never and former smokers did not change their status with time,
while 22.2% of current smokers sustained quitting. This is encouraging and could be
improved with adequate supportive methods. In comparison to available data, this
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study confirms the difficult task of identifying subjects at risk of a negative behavioral
change.
Introduction
Cigarette smoking is the most important modifiable risk factor for premature death in the
world, causing more than 6.4 million deaths yearly [1] and representing 5.7% of global health
expenditure [2]. Prevalence of smoking varies between 8.7% to more than 35% in European
countries with differing trends [3]. In Switzerland, smoking prevalence declined from 33% in
1997 to 28% in 2007, due to an increase in funding for tobacco control [4]. National data
showed that, in 2015, 25% of Swiss adults smoked and that this prevalence tended to stabilize
[5], but a recent study suggested that this prevalence might be underestimated [6].
A European study conducted in 2010 showed that older age, being divorced, having
friends/family or parents who smoke were all significantly associated with ever smoking [7].
The influence of peers was also reported in Italy [8] and in a larger European study [9]. Inter-
estingly, the last study found no association between design and marketing features of tobacco
products and early initiation of regular smoking [9]. We have previously shown that over two
third of Swiss smokers want to quit, but that only a small part wishes to do so in the short term
[10]. Further, a study using nationally representative Swiss data showed an educational and
income gradient in successful quitting and abstinence duration in favor of the people with
higher socio-economic status [11].
Importantly, in these last studies, other sociodemographic covariates (place of birth and age
of youngest child for example), clinical covariates, lifestyle, psychiatric disorders and use of
smoking cessation aids use were not analysed. Also, most studies assessing the determinants of
smoking initiation and cessation were either cross-section or conducted among adolescents
and young adults [12], and information is lacking regarding middle-aged subjects using pro-
spective data. Therefore, we aimed to assess the trends and determinants of smoking status in
a middle aged, population-based cohort followed for a 10.9-year period.
Population and methods
Study design
The CoLaus Study (www.colaus.ch) aims to assess the prevalence of cardiovascular risk factors
and to identify new molecular determinants of these risk factors in participants aged 35–75
years living in the city of Lausanne (Switzerland). The sampling procedure of the CoLaus
Study has been described previously [13]. Briefly, the source population was defined as all sub-
jects aged between 35 and 75 years of the population register of the city. All subjects living in
Lausanne for more than 90 days have their names included in the register, which also includes
information on age and sex. A simple, non-stratified random sample of 19,830 subjects (corre-
sponding to 35% of the source population) was drawn and the selected subjects were invited
by letter. If no answer was obtained, a second letter was sent, and if no answer was obtained,
the subjects were contacted by phone. The baseline study began in June 2003 and ended in
May 2006. The first follow-up was performed between April 2009 and September 2012, 5.6
years on average after baseline; The second follow-up was performed between May 2014 and
July 2017, 10.9 years on average after baseline. All study periods included an interview, a physi-
cal exam and blood analysis.
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Smoking status
Smoking status was assessed at baseline, first and second follow-ups using self-reported data.
Smoking status was defined as never, former (irrespective of the time since quitting) and
current.
When a participant reported being a never smoker at one follow-up and had reported being
current or former in the previous examination, the status was corrected to “former” (n = 37,
0.9%).
Participants who shifted their condition at first and/or second follow-up were secondly cat-
egorized into three subgroups: initiators if they were never smokers before and reported start-
ing smoking; relapsers if they reported restarting smoking; quitters if they were current
smokers at baseline if they reported quitting smoking at FU1 and FU2 (i.e. category CFF).
Covariates
Socio-demographic and clinical covariates were collected by self-filled questionnaires, inter-
view and/or physical examination. Educational level was categorized as low (obligatory school
or apprenticeship), medium (high school), or high (university degree). Marital status was cate-
gorized into living as a couple or alone. Nationality was defined as Swiss born and other. Per-
sonal and family history of cardiovascular or pulmonary events were considered as present if
the participant responded positively to the questions “have you or a member of your family
(parents, siblings or children) been told that you had a cardiovascular disease (angina, myocar-
dial infarction, stroke)” and “have you or a member of your family (parents, siblings or chil-
dren) been told that you had lung disease (asthma, emphysema or chronic bronchitis)”
We defined participants as physically active if they exercised at least 20 minutes of leisure
time physical activity per week [14, 15]. Alcohol consumption was self-reported and expressed
in standard units consumed per week [16] or as alcohol drinkers (yes/no).
Personal history of anxiety and depression was collected by questionnaire (self-reported).
In a subgroup of participants (n = 3719) aged between 35 and 66 years, current and previous
occurrence of anxiety, depression and substance abuse were evaluated by a structured inter-
view (PsyCoLaus study). Details of the methodology and characteristics of the PsyCoLaus sam-
ple have been previously described [17]. Briefly, the psychiatric baseline evaluations included
the French version of the semi-structured Diagnostic Interview for Genetic Studies (DIGS)
[18, 19]. In this study, we grouped all types of anxiety disorder and all types of depression. Sub-
stance abuse (ever or current) was defined as taking either THC, cocaine, amphetamines, sol-
vents or opiates.
For participants with children (n = 3888), age of the youngest child was collected and cate-
gorized into <5 and5 years. Our hypothesis was that parents with younger children would
quit smoking to protect their children against the effects of second hand smoking.
Participants reported which medicines (prescribed or obtained over the counter) they con-
sumed. Intake of smoking cessation aids, bupropion, varenicline and nicotine replacement
therapy was obtained for baseline, first and second follow-ups. Due to differences in coding
between surveys, the intake of varenicline and nicotine had to be grouped in a single variable.
Body weight and height were measured with participants standing without shoes in light
indoor attire. Body weight was measured in kilograms to the nearest 100 g using a Seca1 scale
(Hamburg, Germany). Height was measured to the nearest 5 mm using a Seca1 (Hamburg,
Germany) height gauge. Blood pressure (BP) was measured using an Omron1 HEM-907
automated oscillometric sphygmomanometer after at least a 10-minute rest in a seated posi-
tion, and the average of the last two measurements were used. Overweight was defined as 25
body mass index (BMI)<30 kg/m2 and obesity as BMI30 kg/m2.
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Blood samples were collected after an overnight fast and biological assays were performed
by the Clinical Laboratory of the Lausanne university hospital on fresh blood samples within 2
hours of blood collection. All measurements were conducted in a Modular P apparatus (Roche
Diagnostics, Switzerland). The following analytical procedures (with maximum inter and
intra-batch CVs) were used: total cholesterol by CHOD-PAP (1.6%–1.7%); HDL-cholesterol
by CHOD-PAP + PEG + cyclodextrin (3.6%–0.9%); triglycerides by GPO-PAP (2.9%–1.5%)
and glucose by glucose dehydrogenase (2.1%–1.0%). LDL-cholesterol was calculated using the
Friedewald formula.
Dyslipidemia was defined as an HDL-cholesterol <1 mmol/L in men and<1.29 mmol/L in
women and/or LDL-cholesterol4.1 mmol/L (2.6 mmol/L if personal history of CVD or
diabetes) and/or triglyceride2.2 mmol/L and/or presence of a hypolipidemic drug treatment.
Hypertension was defined as a systolic BP140 mm Hg and/or diastolic BP90 mm Hg and/
or presence of an antihypertensive drug treatment. Diabetes was defined as a fasting plasma
glucose7 mmol/L and/or presence of oral hypoglycaemic or insulin treatment.
Exclusion criteria
We excluded patients who a) missed smoking data at baseline, first or second follow-up; b) did
not participate in the follow-up (first or second) and c) missed covariates at baseline.
Statistical analysis
Statistical analyses were performed using Stata version 15.0 for windows (Stata Corp, College
Station, Texas, USA). Descriptive results were expressed as number of participants (percent-
age) for categorical variables and as average ± standard deviation or median and [interquartile
range] for continuous variables. Bivariate analyses were performed using chi-square or Fisher’s
exact test for qualitative variables and Student’s t-test, analysis of variance or Kruskall-Wallis
test for quantitative variables.
Multivariable analysis was performed using stepwise logistic regression and the results were
expressed as multivariable-adjusted odds ratio (OR) and 95% confidence interval (CI). Both
forward and backward logistic regressions were performed to assess consistency of the results.
All variables included in the bivariate analysis (i.e. sex, age, education, country of birth, marital
status, BMI categories, personal and family history of cardiovascular and lung disease, hyper-
tension, dyslipidaemia, diabetes, alcohol consumption, physical activity, anxiety and depres-
sion) were included in the stepwise process. Multivariable analysis were performed in two
steps.
Firstly, we analysed factors associated with initiating, relapsing or quitting and maintaining
quitting (i.e. category “CFF”) among never, former and current smokers, respectively. Second,
sensitivity analyses were conducted as follows: 1) including age of the youngest child in the
model and 2) using the psychological assessments performed in PsyCoLaus instead of the self-
reported ones. The first sensitivity analysis was conducted because we hypothesized that
parents with young children might change their smoking habits to prevent second-hand smok-
ing. The second sensitivity analysis used objective, professionally diagnosed diseases instead of
self-reported ones. Statistical significance was assessed for a two-sided test with p<0.05.
Ethical statement
The institutional Ethics Committee of the University of Lausanne (Canton de Vaud, Commis-
sion cantonale d’e´thique de la recherche sur l’être Humain; Available from: http://www.cer-vd.
ch/2014) approved the baseline CoLaus study (protocol reference 16/03, decisions of 13th Janu-
ary and 10th February 2003) and the approval was renewed for first (protocol reference 33/09,
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decision of 23rd February 2009) and second (reference 26/14, decision of 11th March 2014) fol-
low-ups. The full decisions can be obtained from authors upon request. The study was per-
formed in agreement with the Helsinki declaration and in accordance with the applicable
Swiss legislation. All participants gave their signed informed consent before entering the
study.
Results
Characteristics of participants
Of the initial 6733 participants, 3999 (59.4%) were retained for analysis. The reasons for exclu-
sion are indicated in Fig 1 and the characteristics of included and excluded participants are
summarized in S1 Table. Included participants were younger, more often women, with higher
education level, living in coupled circumstance and born in Switzerland. They reported less
anxiety and depression, were more engaged in a physical activity, had a lower BMI, lower levels
of hypertension, dyslipidemia and diabetes, and less personal history of cardiovascular disease
(CVD). Included participants also were more often alcohol drinkers and had more often a
family history of lung disease. Finally, included participants were more frequently former
smokers and less frequently current smokers.
The baseline characteristics of the included participants according to smoking status are
summarized in Table 1.
Fig 1. Number of participants excluded and retained for analysis.
https://doi.org/10.1371/journal.pone.0200010.g001
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Trends in smoking categories
The different smoking categories at baseline, first and second follow-ups are summarized in
Fig 2. Most participants did not change their smoking status during follow-up. Among all par-
ticipants, almost 40% of participants remained never smokers, 30% former smokers and 14%
current smokers. Approximately 36% of current smokers at baseline quitted smoking at FU1
and/or FU2. During the study period, more than 90% of never, 90% of former and almost 60%
of current smokers at baseline retained their status after 10 years (Fig 2).
Table 1. Baseline characteristics of never, former and current smokers, CoLaus study, Lausanne, Switzerland.
Baseline smoking status Never Former Current P-value
N 1653 1373 973
Sex (male) 637 (38.5) 707 (51.2) 457 (47.0) <0.001
Age categories <0.001
[35–44] 557 (33.7) 340 (24.8) 347 (35.7)
[45–54] 447 (27.0) 437 (31.8) 337 (34.6)
[55–64] 441 (26.7) 399 (29.1) 221 (22.7)
[65–75] 208 (12.6) 197 (14.3) 68 (7.0)
Education level <0.001
University 389 (23.5) 324 (23.6) 180 (18.5)
High school 443 (26.8) 384 (28.0) 252 (25.9)
Apprenticeship 557 (33.7) 507 (36.9) 368 (37.8)
Primary level 264 (16.0) 158 (11.5) 173 (17.8)
Born in Switzerland 1069 (64.7) 905 (65.9) 606 (62.3) 0.191
Marital status (in couple) 1136 (68.7) 989 (72.0) 609 (62.6) <0.001
Personal history
Cardiovascular disease 63 (3.8) 100 (7.3) 34 (3.5) <0.001
Lung disease 178 (10.8) 164 (11.9) 124 (12.7) 0.287
Family history
Cardiovascular disease 625 (37.8) 575 (41.9) 339 (34.8) 0.002
Lung disease 405 (24.5) 369 (26.9) 228 (23.4) 0.132
Hypertension 506 (30.6) 490 (35.7) 247 (25.4) <0.001
Body mass index categories <0.001
Normal 908 (54.9) 630 (45.9) 539 (55.4)
Overweight 540 (32.7) 534 (38.9) 339 (34.8)
Obese 205 (12.4) 209 (15.2) 95 (9.8)
Dyslipidaemia 557 (33.7) 558 (40.7) 3 89 (40.0) <0.001
Diabetes 58 (3.5) 90 (6.5) 40 (4.1) <0.001
Alcohol drinker 120 (67.8) 1098 (80.0) 784 (80.6) <0.001
Physically active 982 (59.4) 823 (59.9) 460 (47.3) <0.001
Anxiety, self-reported 123 (7.4) 112 (8.2) 101 (10.4) 0.030
Depression, self-reported 220 (13.3) 232 (16.9) 191 (19.6) <0.001
Sensitivity analyses
Child aged <5 years 137 (14.1) 82 (10.2) 65 (12.5) 0.048
Diagnosed psychiatric diseases 729 (44.1) 790 (57.5) 698 (71.7)
Substance use, ever 39 (2.4) 154 (11.2) 171 (17.6) <0.001
Anxiety, ever 251 (15.2) 246 (17.9) 186 (19.1) 0.109
Depression, ever 439 (26.6) 390 (28.4) 341 (35.0) 0.006
Results are expressed as number of participants (percentage) for categorical data. Between-group comparisons using chi-square test.
https://doi.org/10.1371/journal.pone.0200010.t001
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Determinants of quitting smoking
Among the 973 current smokers, 216 (22.2%) quit and remained former smokers for at least 5
years. The bivariate analysis of the factors associated with quitting is summarized in Table 2.
Increasing age had a higher frequency of quitting. This was further confirmed in both forward
and backward multivariable analysis. Relative to the age group [35–44], the OR and 95% CI
were 0.76 (0.51–1.13), 1.52 (1.01–2.30) and 2.76 (1.50–5.09) for age groups [45–54], [55–64]
and [65–75], respectively (p-value for trend <0.001) (S2 Table). The first sensitivity analysis
confirmed the association between age and quitting (p-value for trend <0.001) and identified
children aged<5 years [0.41 (0.21–0.80)] and dyslipidemia [0.59 (0.37–0.93)] as being nega-
tively associated with quitting. The second sensitivity analysis showed that relative to univer-
sity level, the OR and 95% CI were 0.61 (0.36–1.06), 0.52 (0.31–0.88) and 0.56 (0.30–1.07)
for igh school, apprenticeship and basic school, respectively (p-value for trend = 0.064)
(S2 Table).
Determinants of relapsing smoking
Among the 1373 former smokers, 149 (10.9%) relapsed. The bivariate analysis of the factors
associated with smoking relapse is summarized in Table 2. Increasing age had a lower fre-
quency of relapse, and this was further confirmed in both forward and backward stepwise
multivariable analysis: relative to the age group [35–44], the OR and 95% CI were 0.60 (0.40–
0.90), 0.37 (0.23–0.59) and 0.20 (0.09–0.42) for age groups [45–54], [55–64] and [65–75],
respectively (p-value for trend<0.001). The multivariable analysis also identified family his-
tory of lung disease as being positively associated with relapse: 1.53 (1.06–2.21) (S2 Table).
The first sensitivity analysis confirmed age as being inversely associated with relapse in both
the forward and the backward selection procedure (p-value for trend<0.001), while no effect
was found for family history of lung disease. The second sensitivity analysis confirmed age
Fig 2. Smoking categories at baseline, first a second follow-up.
https://doi.org/10.1371/journal.pone.0200010.g002
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(p-value for trend<0.001) and family history of lung disease [1.59 (1.03–2.46)] as being associ-
ated with relapse (S2 Table).
Table 2. Bivariate analysis of the factors associated with initiation, relapse or quitting smoking, CoLaus study, Lausanne, Switzerland.
Initiators § Relapsers ‡ Quitters †
No Yes p-value No Yes p-value No Yes p-value
N 1525 128 1224 149 569 216
Sex (male) 579 (38.0) 58 (45.3) 0.101 631 (51.6) 76 (51.0) 0.900 255 (44.8) 105 (48.6) 0.341
Age categories 0.943 <0.001 <0.001
[35–44] 516 (33.8) 41 (32.0) 280 (22.9) 60 (40.3) 201 (35.3) 71 (32.9)
[45–54] 410 (26.9) 37 (28.9) 386 (31.5) 51 (34.2) 219 (38.5) 57 (26.4)
[55–64] 408 (26.8) 33 (25.8) 369 (30.2) 30 (20.1) 122 (21.4) 63 (29.2)
[65–75] 191 (12.5) 17 (13.3) 189 (15.4) 8 (5.4) 27 (4.8) 25 (11.6)
Education level 0.350 0.123 0.082
University 360 (23.6) 29 (22.7) 280 (22.9) 44 (29.5) 94 (16.5) 53 (24.5)
High school 408 (26.8) 35 (27.3) 338 (27.6) 46 (30.9) 155 (27.2) 51 (23.6)
Apprenticeship 520 (34.1) 37 (28.9) 463 (37.8) 44 (29.5) 221 (38.8) 77 (35.6)
Primary 237 (15.5) 27 (21.1) 143 (11.7) 15 (10.1) 99 (17.4) 35 (16.2)
Born in Switzerland 993 (65.1) 76 (59.4) 0.192 813 (66.4) 92 (61.7) 0.255 373 (65.6) 128 (59.3) 0.101
Marital status (in couple) 1057 (69.3) 79 (61.7) 0.075 878 (71.7) 111 (74.5) 0.478 340 (59.8) 137 (63.4) 0.347
Personal history
Cardiovascular disease 57 (3.7) 6 (4.7) 0.590 92 (7.5) 8 (5.4) 0.341 19 (3.3) 9 (4.2) 0.577
Lung disease 165 (10.8) 13 (10.2) 0.816 146 (11.9) 18 (12.1) 0.957 66 (11.6) 32 (14.8) 0.224
Family history
Cardiovascular disease 580 (38.0) 45 (35.2) 0.519 515 (42.1) 60 (40.3) 0.673 195 (34.3) 73 (33.8) 0.900
Lung disease 375 (24.6) 30 (23.4) 0.771 318 (26) 51 (34.2) 0.032 135 (23.7) 49 (22.7) 0.759
Hypertension 463 (30.4) 43 (33.6) 0.446 444 (36.3) 46 (30.9) 0.194 137 (24.1) 63 (29.2) 0.144
Body mass index categories 0.422 0.120 0.991
Normal 841 (55.2) 67 (52.3) 550 (44.9) 80 (53.7) 315 (55.4) 120 (55.6)
Overweight 492 (32.3) 48 (37.5) 483 (39.5) 51 (34.2) 200 (35.2) 75 (34.7)
Obese 192 (12.6) 13 (10.2) 191 (15.6) 18 (12.1) 54 (9.5) 21 (9.7)
Dyslipidemia 512 (33.6) 45 (35.2) 0.716 507 (41.5) 51 (34.5) 0.102 238 (42.0) 83 (37.5) 0.367
Diabetes 54 (3.5) 4 (3.1) 0.806 83 (6.8) 7 (4.7) 0.332 27 (4.8) 9 (4.2) 0.729
Alcohol drinker 1035 (67.9) 85 (66.4) 0.734 983 (80.3) 115 (77.2) 0.368 450 (79.1) 173 (80.1) 0.756
Physically active 907 (59.5) 75 (58.6) 0.845 736 (60.1) 87 (58.4) 0.682 249 (43.8) 107 (49.5) 0.147
Anxiety, self-reported 111 (7.3) 12 (9.4) 0.385 97 (7.9) 15 (10.1) 0.367 60 (10.5) 21 (9.7) 0.735
Depression, self-reported 206 (13.5) 14 (10.9) 0.411 200 (16.3) 32 (21.5) 0.114 118 (20.7) 36 (16.7) 0.200
N ‡ 892 81 709 94 296 126
Child aged <5 years ‡ 128 (14.4) 9 (11.1) 0.422 66 (9.3) 16 (17.0) 0.020 32 (10.8) 20 (15.9) 0.148
Diagnosed, N ¶ 979 79 781 107 417 140
Substance use, ever 31 (3.2) 8 (10.1) 0.002 132 (16.9) 22 (20.6) 0.348 104 (24.9) 27 (19.3) 0.172
Anxiety, ever 230 (23.5) 21 (26.6) 0.535 209 (26.8) 37 (34.6) 0.090 122 (29.3) 33 (23.6) 0.194
Depression, ever 414 (42.3) 25 (31.7) 0.065 336 (43) 54 (50.5) 0.146 196 (47.0) 74 (52.9) 0.230
§ among never smokers at baseline
‡ among former smokers at baseline
† among current smokers at baseline
‡, among participants with children
¶, among participants in the PsyCoLaus study.
Results are expressed as number of participants (percentage); between-group comparisons using chi-square.
https://doi.org/10.1371/journal.pone.0200010.t002
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Determinants of smoking initiation
Among the 1653 never smokers, 128 (7.7%) initiated smoking. The bivariate analysis of the
factors associated with smoking initiation is summarized in Table 2. No clinical or lifestyle fac-
tor was associated with initiation; backward multivariable analysis identified male gender OR
and 95% CI: 1.46 (1.01–2.12) and living in as a couple 0.66 (0.45–0.97) as being associated with
smoking initiation, while no variable was found in the forward procedure (S2 Table). The first
sensitivity analysis confirmed the association between gender and smoking initiation in both
the forward and the backward selection procedure: 1.60 (1.02–2.53). The second sensitivity
analysis showed substance abuse [3.70 (1.62–8.42)] and depression [0.60 (0.37–0.99)] to be
associated with initiation, while the effect of male gender was no longer significant (S2 Table).
Discussion
Few studies have assessed the determinants of smoking initiation and cessation among mid-
dle-aged subjects. Using 10-year prospective data, we show that, among people aged 35 to 75
years, the majority of never and former smokers retain their status, while four out of ten smok-
ers will make at least one quit attempt and one fifth will quit and maintain this status for at
least 5 years. Our results also show that quitting is positively associated with older age and neg-
atively associated with having children aged <5 years or dyslipidaemia. Relapsing is positively
associated with younger age and family history of lung disease, while initiation is positively
associated with male gender, living alone and substance abuse, and negatively associated with
depression.
Smoking prevalence
Prevalence of current smokers at baseline was 24.3%, a value comparable to Swiss national
data in 2015 (25% of Swiss adults) but lower than pooled data from the 2001–2007 editions of
the Swiss Tobacco Monitoring Survey (30.9%) [11]. A first explanation is that the former study
included participants aged 14–65 years-old, thus over 10-years younger than our participants
(35–75 years-old). A second explanation is the fact that our study was a prospective one, and it
is well known that smokers tend to quit more frequently [20]; hence, it is likely that the preva-
lence of current smokers in our study is underestimated.
Determinants of quitting smoking
Approximately one in five current smokers sustained quitting, a value considerably higher than
reported in an Italian study (6.9%) [21]. A possible explanation is that the latter study was partly
based on data derived from periods during which funding for tobacco control and public health
measures were limited. Another possible explanation is that the Italian study included partici-
pants aged 25–64 years-old, thus 10-years younger than our participants (35–75 years-old).
Indeed, increasing age was positively associated with quitting smoking. This finding is in
agreement with findings from Marti who showed that older smokers are more likely to quit
successfully compared with smokers aged 18–24 years [11]. It is also in agreement with the
previous finding that increasing age is negatively associated with the risk of relapsing. A likely
explanation is that former smokers quit because of current tobacco-related health conditions
and because of the future harmful effect of smoking on health [22]. As older smokers have
more tobacco-related health conditions and more comorbidities, they are motivated to quit
more often.
Dyslipidaemia was negatively associated with quitting smoking. Our finding partly dis-
agrees with a previous cohort study [23] which showed that newly diagnosed dyslipidaemia
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was positively associated with quitting. However, the positive association was only significant
for men and no association was found for known dyslipidaemia. Furthermore, the latter study
was based on subjects aged 40 years at baseline. A possible explanation is that a significant frac-
tion of dyslipidaemic subjects are not aware of their status [24, 25] and thus do not take pre-
ventive measures to reduce their CV risk factor levels.
Lower educational level tended to be negatively associated with quitting in the second sensi-
tivity analysis. This is in agreement with a previous study conducted in Switzerland showing a
positive educational and income gradient in successful cessation and abstinence duration for
both genders [11]. The reasons for lower educated subjects to be less prone to quit smoking
are varied [26]. Lower educated subjects have a lower health literacy, making them less recep-
tive to preventive messages [27]. Lower health literacy is also associated with more positive
smoking outcome expectancies (e.g., smoking facilitates social interactions, smoking reduces
boredom or negative affect) and less negative smoking outcome expectancies (e.g., smoking is
harmful to health) [26].
Having a child aged<5 years was negatively associated with quitting smoking. This unex-
pected finding is in disagreement with a previous cross-sectional study [28] which showed that
parents with a child under age 3 years had higher odds of successfully quitting at 12 months.
One possible explanation for our finding is that participants with children aged <5 years were
younger (41.3±5.5 vs. 54.1±9.6 years, p<0.001), and that increasing age was positively associ-
ated with quitting smoking.
Determinants of smoking relapse
Approximately 11% of former smokers relapsed during follow-up. This value is lower than the
relapse rate reported in a workplace study conducted in Switzerland (14.4% after intervention
and 31.1% at one year) [29]. Still, as relapse rates are dependent of several factors such as
smoking dependency or time after quitting, comparison with other studies is difficult, as those
variables were not collected in our study.
Increasing age was negatively associated with smoking relapse, a finding in agreement with
a previous study [30]. Our results suggest that as age increases, likelihood of relapsing
decreases, possibly due to the occurrence of tobacco-(un)related diseases and the subsequent
increased pressure from health professionals to stop smoking.
Family history of lung disease was positively associated with smoking relapse. To our
knowledge, this is the first study assessing the association between personal or family history
of lung disease and smoking relapse. Previous studies showed that having parents who smoke
was significantly associated with smoking [7–9]. Thus, participants with family history of lung
disease may be more prone to relapse because of a more unfavorable family environment
regarding smoking.
Determinants of smoking initiation
In our study, 7.7% never smokers initiated smoking in this older group, a value considerably
higher than reported in New Zealand (<1.0%) [31]. A possible explanation is the fact that
Switzerland has only a partial smoking ban and further restrictions have been rejected by the
population [32]. Switzerland is one of the few European countries which has signed but not
ratified The Framework Convention on Tobacco Control [33]. There is therefore a permissive
politic with relatively low prices for tobacco, few restrictions on marketing in particular indi-
rect marketing and easy access to tobacco products. We postulate that the rather benevolent
legislation regarding smoking in Switzerland might favour smoking initiation even among
middle-aged subjects.
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Male gender was positively associated with smoking initiation. This finding is in agreement
with several cohort studies conducted among North American adults and adolescents [34–37],
but not with a recent cohort study conducted among young Canadian adults [38]. Possible
explanations include a lower health awareness among men and the fact that men still consider
smoking as a masculine characteristic, although a better assessment of the rationale for mid-
dle-aged men to initiate smoking is needed.
Living as a couple was negatively associated with smoking initiation. This finding is in
agreement with two cohort studies [34, 39] and another Swiss [11] and European [7] cross-sec-
tional studies. A possible explanation is the mutual psychological support and influence, which
might prevent smoking initiation.
Substance abuse was strongly associated with smoking initiation. This finding is in agree-
ment with a systematic review [37] which showed that the use of alcohol and illegal drugs was
associated with smoking initiation. Similarly, a cohort study [34] among American adults con-
firmed that substance use disorder is associated with smoking initiation. Possible explanations
include a genetic predisposition regarding joint consumption of tobacco and other substances,
as well as environmental conditions favouring multisubstance use [40].
No association was found between self-reported depression and smoking initiation in the
initial analyses, while on sensitivity analysis a negative association between having been ever
depressed and smoking initiation was found. This latter finding disagrees with other studies,
which have shown a positive association between depression and smoking initiation [34, 41–
43]. Several explanations can be put forward to explain these contrasting results. Firstly, most
studies focused on adolescents [41–43], and the reasons for smoking initiation in adolescents
might differ from those among middle-aged adults [44]. Secondly, depression was grouped
with all axis I clinical disorders in one study [34] and based on self-reported symptoms in oth-
ers [41–43], while in our sensitivity analysis it was objectively diagnosed using validated crite-
ria. Indeed, a possible explanation for the negative association between depression and
smoking initiation is that depressed subjects are advised by their doctors not to use smoking as
a deterrent for their depressive symptoms. Still, the association between depression and smok-
ing initiation needs further investigation.
Strengths and limitations
To our knowledge, this is the first study exploring demographic, clinical, psychiatric and life-
style determinants of smoking changes in a population-based sample.
This study has also some limitations. Firstly, participants excluded from the analysis were
more frequently smokers. Hence, it is likely that the smokers included in the analysis were
more health conscious and thus more prone to quit; our quitting rates might be overestimated.
Secondly, despite collecting smoking cessation aids (bupropion and varenicline/nicotine), we
could not include them in our analysis for different reasons. Indeed, Bupropion was also pre-
scribed as an antidepressant for never smokers and current smokers. Therefore, we could not
analyse its association with quitting smoking. On the other hand, despite being the most com-
monly (16.2%) used smoking cessation aid in Switzerland in 2013(41), six participants only
reported using nicotinic replacement. In spite of asking for prescribed or obtained over the
counter medicines in our questionnaires, participants may have probably under-reported nic-
otinic replacement. Thirdly, it was not possible to assess duration of smoking/quitting, or the
magnitude of smoking dependency at baseline. Hence, it was not possible to assess whether
tobacco-related factors influenced smoking trajectories, although it has been shown that
increased tobacco dependency negatively influences quitting [45]. Fourthly, smoking status
was assessed during the baseline and follow-up visits, and we have no information regarding
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smoking status between visits. Hence, a participant might be considered as a quitter in both
follow-ups while he/she actually relapsed and quit again between visits. Hence, our quitting
rates might be overestimated. Still, our results show that one fifth of current smokers will quit
over 10 years, which is encouraging and could be even improved if adequate supportive meth-
ods were provided.
Conclusion
In this population-based prospective study, most middle-aged never and former smokers do
not change their status with time, while one fifth of current smokers will quit permanently.
The determinants of change vary according to the smoking status. In comparison to available
data, this study confirms the difficult task to identify subjects at risk of negative behaviour
change.
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